Figure S1 related to Figure 2 Figure S1. Related to Figure 2 . DAPT treatment and overexpression of NICD or DnMaml1-eGFP potently alter Notch signaling. Addition of doxycycline on day 3 of differentiation results in robust induction of (A) NICD-V5 or (B) DnMaml1-eGFP in day 4 motor neuron progenitors. C. NICD induction increases Hes5 expression by 1.3 ± 0.02 (log2 fold). DnMaml1-eGFP overexpression and DAPT treatment reduce Hes5 expression by 1.9 ± 0.1 and 2.1 ± 0.1 (log2 fold) respectively. Data reported as mean ± SEM (n=3). D. DAPT-treated and control cultures are treated with BrdU on the morning and evening of day 4. The number of unlabeled motor neurons is the same after day 4 AM addition of BrdU. In contrast, in day 4 PM BrdU cultures, the number of unlabeled motor neurons is greatly increased in DAPT treated cultures, revealing accelerated motor neuron generation in DAPT treated cultures. Scale bar marks 50µm. E. Quantification of unlabeled (BrdU In control condition 71.8 ± 3.2% of motor neurons co-express Lhx3. DAPT treatment on pMNs from days 3-6, 4-6 and 4-5 reduce Lhx3 expression to 18.4 ± 5.9 (n=3, P=.019), 17.8 ± 2.0 (n=3, P<.001), and 13.2 ± 1.6% (n=3, P<.001) of motor neurons respectively. After DAPT treatment from day 5-6, when motor neurons are already postmitotic, Lhx3 expression remains unchanged at 75.1 ± 11.5% of motor neurons (n=3, P= .80), revealing that Notch signaling controls motor neuron subtype identity in pMNs. Data reported as mean ± SEM (n=3 from three EBs per differentiation). 
